Search Login Register

aliskiren Summary

Description: orally active nonpeptidic renin inhibitor

Also Known As: 2(S),4(S),5(S),7(S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarate; CGP 060536B; CGP-060536B; CGP060536B; SPP100 Show All >>

Networked: 559 relevant articles (117 outcomes, 191 trials/studies) for this Drug

Key Diseases for which aliskiren is Relevant

  1. Hypertension (High Blood Pressure) : 49 outcomes 86 studies in 297 results
  2. Fibrosis (Cirrhosis) : 10 outcomes 6 studies in 29 results
  3. Diabetic Nephropathies (Diabetic Nephropathy) : 8 outcomes 10 studies in 35 results
  4. Insulin Resistance : 8 outcomes in 8 results
  5. Proteinuria : 7 outcomes 15 studies in 43 results
Show All >>

Drugs Related to aliskiren

  1. Renin
  2. valsartan (Vals)
  3. Amlodipine (Norvasc)
  4. Hydrochlorothiazide (Esidrix)
  5. Losartan (Cozaar)
  6. Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
  7. Angiotensin Receptor Antagonists
  8. Enalapril
  9. Angiotensin Receptors (Angiotensin II Receptor)
  10. Insulin (Novolin)
Show All >>

Therapies Related to aliskiren

  1. Oral Administration
  2. Transplantation (Transplant Recipients)
  3. Intraventricular Infusions
  4. Ligation
  5. Renal Dialysis (Hemodialysis)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.